GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Laboratorios Richmond SACIF RICH.BA · ARS

Health Care · Buenos Aires · 🇦🇷 Argentina

Compare

1,395.00

+7.31%

Close of 6 Nov 2026, in ARS

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ARS, from our data supplier.

FY2024

Revenue

ARS 91.79bn

FY2015FY2024

Net income

ARS 23.85bn

FY2015FY2024

Free cash flow

−ARS 3.19bn

FY2015FY2024

Shareholders' equity

ARS 64.30bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueARS 91.79bnARS 39.03bnARS 18.47bnARS 32.37bnARS 9.33bnARS 5.30bnARS 2.80bnARS 1.59bnARS 856.0mARS 446.4m
Operating incomeARS 15.57bnARS 5.31bnARS 2.97bnARS 4.49bnARS 2.33bnARS 1.06bnARS 172.8mARS 196.3mARS 240.5mARS 98.6m
Net incomeARS 23.85bn−ARS 10.85bnARS 163.4mARS 1.15bnARS 733.9mARS 158.5m−ARS 331.7mARS 48.7mARS 94.8mARS 5.8m
Diluted earnings per share295.29-134.372.0214.279.091.96-4.110.601.420.09

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsARS 260.15bnARS 154.90bnARS 40.72bnARS 50.05bnARS 12.94bnARS 6.99bnARS 4.16bnARS 2.58bnARS 861.1mARS 532.8m
Cash and short-term investmentsARS 9.97bnARS 823.0mARS 2.69bnARS 14.34bnARS 796.9mARS 298.0mARS 771.6mARS 798.1mARS 23.9mARS 16.9m
Total liabilitiesARS 195.86bnARS 132.35bnARS 30.63bnARS 39.74bnARS 7.83bnARS 4.20bnARS 2.54bnARS 1.32bnARS 671.7mARS 436.7m
DebtARS 143.61bnARS 94.15bnARS 21.45bnARS 22.37bnARS 2.61bnARS 779.1mARS 649.5mARS 440.4mARS 230.8mARS 172.3m
Shareholders' equityARS 64.30bnARS 22.55bnARS 10.09bnARS 10.31bnARS 5.10bnARS 2.79bnARS 1.62bnARS 1.25bnARS 189.5mARS 96.1m
Shares outstanding81m81m81m81m81m81m81m81m67m67m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsARS 5.62bn−ARS 2.51bn−ARS 4.29bnARS 7.27bn−ARS 181.3mARS 121.0m−ARS 182.2mARS 11.2m−ARS 3.7m−ARS 25.4m
Capital spending−ARS 8.81bn−ARS 12.52bn−ARS 7.52bn−ARS 11.55bn−ARS 918.0m−ARS 612.1m−ARS 389.4m−ARS 108.6m−ARS 22.8m−ARS 8.4m
Free cash flow−ARS 3.19bn−ARS 15.02bn−ARS 11.80bn−ARS 4.27bn−ARS 1.10bn−ARS 491.1m−ARS 571.6m−ARS 97.4m−ARS 26.5m−ARS 33.8m
Dividends paid——−ARS 218.9m−ARS 116.6m——−ARS 21.1m−ARS 40.1m−ARS 1.5m—

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueARS 30.88bnARS 25.18bnARS 27.02bnARS 33.95bnARS 19.71bnARS 38.13bnARS 17.04bnARS 19.83bn
Operating incomeARS 7.47bnARS 4.62bnARS 4.44bnARS 7.26bnARS 3.44bnARS 4.86bnARS 2.08bnARS 5.10bn
Net income−ARS 9.17bn−ARS 2.81bnARS 5.67bnARS 5.83bnARS 5.55bnARS 12.46bnARS 8.15bn−ARS 7.61bn
Diluted earnings per share-113.57-34.8270.1572.2268.76154.31100.98-94.27
Total assetsARS 354.98bnARS 321.71bnARS 295.13bnARS 260.15bnARS 247.97bnARS 212.09bnARS 189.65bnARS 154.90bn
Cash and short-term investmentsARS 3.92bnARS 4.23bnARS 4.51bnARS 9.97bnARS 9.31bnARS 1.84bnARS 2.14bnARS 823.0m
DebtARS 177.96bnARS 157.48bnARS 137.40bnARS 125.04bnARS 122.09bnARS 100.89bnARS 93.51bnARS 84.49bn
Shareholders' equityARS 71.22bnARS 75.20bnARS 75.48bnARS 64.30bnARS 60.57bnARS 49.41bnARS 39.78bnARS 22.55bn

Financial ratios

Data as of 6 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2012FY2011FY2009FY2008FY2007
Operating margin18.2%—13.6%16.1%14.0%37.7%20.4%—————
Net margin2.4%26.0%-27.8%0.9%3.6%7.9%——————
Return on equity3.4%37.1%-48.1%1.6%11.2%14.4%——————
Return on assets0.7%9.2%-7.0%0.4%2.3%6.0%——————
Free cash flow yield——18.0%1.9%14.0%0.3%0.4%—————
Revenue growth4.9%42.1%360.1%11.2%168.8%58.7%——————
Earnings growth-90.2%-232.7%-14558.2%-72.4%21.6%317.6%——————
Current ratio1.01x1.21x0.86x1.55x1.66x1.52x——————
Debt to equity1.82x1.94x0.35x1.82x0.22x0.27x——————
Equity ratio21.8%24.7%14.6%24.8%20.6%41.6%——————
Interest coverage1.54x—1.00x2.08x3.12x8.32x5.64x—————
R&D as a share of sales———————0.3%0.5%0.1%0.1%2.5%
Buybacks as a share of market value——0.0%0.0%0.0%0.0%——————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue41.5%76.9%74.7%
Operating income51.3%71.1%74.7%
Net income174.6%172.6%127.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.0%15.6%16.2%16.1%
Net margin9.9%7.9%7.7%7.4%

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 14 May 2025.

FY2025
Paid in the year26.89

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.